Islamabad, 25 May 2024, (GNP): Maroof International Hospital (MIH) celebrated International Clinical Trial Day, highlighting the crucial role of clinical trials in medical advancements. Key speakers provided compelling statistics and demonstrated commitment to furthering research.
Dr. Waqar Hafeez, Consultant Neurologist & Executive Director of Maroof Clinical Trial Unit. emphasized the surge in clinical trials in Pakistan. “Data from clinicaltrials.gov reveals a dramatic increase in the number of clinical trials: 469 conducted in 2023 compared to just 215 in 2019,” he highlighted, underscoring the critical need for robust clinical research, especially post-COVID.
Chaudary Naseer Ahmed Chairman MIH congratulated the research team for their commitment to excellence. “Dr. Mujtaba Qadri & Dr. Mir Waheed have been the pioneers, and under Dr. Saboora Waris’ leadership, our clinical trial unit has achieved new heights,” he said.
Haroon Naseer CEO MIH, reaffirmed the hospital’s dedication to advancing medical research. “We will continue pushing the boundaries of medical research to ensure our patients receive the most advanced and effective treatments,” he said, praising the MIH research department’s growth from humble beginnings to a national leader.
Also Read: Korean Embassy announces entries for K-pop Festival in Pakistan
Dr. Mir Abdul Waheed, Medical Director MIH, celebrated the unit’s dedication to life-saving research, announcing, “Our renewal of the DRAP license for Maroof Clinical Trial Unit is a testament to our commitment to conducting high-quality & safe clinical research.”
Dr. Saboora Waris, Director Maroof Clinical Trial Unit/Research & Quality Dept. highlighted Pakistan’s potential in the clinical trial industry. “Our genetic diversity and high disease burden make us an ideal location for impactful clinical research,” she noted, recognizing historical figures like Avicenna and James Lind for their foundational contributions.
Dr. Gulafshana Hafeez HOD Maroof Obs & Gynae Dept. Chairperson Institutional Review Board, emphasized the importance of ethical oversight in clinical research, ensuring patient safety and research integrity.
In her closing remarks, Mrs. Chairman Musarat Naseer shared a touching story of a relative who benefited from an oncology trial, significantly improving her life expectancy.
“This personal experience underscores the life-changing impact of clinical research,” she said.
Rubina Afzal Corporate Head MIH skillfully hosted the event, ensuring its success with outstanding coordination and grace.
The event concluded with Maroof Hospital’s renewed commitment to advancing healthcare through ongoing research, ensuring the delivery of cutting-edge treatments to patients.
